Single nucleotide polymorphisms to predict acute radiation dermatitis in breast cancer patients: A systematic review and meta-analysis

Crit Rev Oncol Hematol. 2022 May:173:103651. doi: 10.1016/j.critrevonc.2022.103651. Epub 2022 Mar 15.

Abstract

Purpose: To identify Single Nucleotide Polymorphisms (SNPs) that can predict acute radiation dermatitis (RD) in breast cancer patients (BC), and the association between SNPs and RD severity.

Methods: We performed the search in seven databases and the gray literature, and a meta-analysis to assess SNPs in patients with RD and to evaluate the association between SNPs and severe RD.

Results: We included sixteen single-arm cohort studies with 4742 BC. The most prevalent SNPs were the TGFβ1 rs1800469 (41%), and the GSTA1 rs3957356 (36%). Seven genotypes were associated with severe RD (PTTG1 rs3811999-CC; PTTG1 rs2961950-AA; MAD2L2 rs2294638-GG; MAT1A rs2282367-GG; GSTA1 rs3957356-CT; CD44 rs8193-CT; SH3GL1 rs243336-GC) and five SNPs were associated with lower RD (PTTG1 rs2961952-GG; CD44 rs8193-CC; PTTG1 rs3811999-CT; MAT1A rs2282367-GA; OGG1 rs2075747-AA).

Conclusions: The genotyping of SNPs more prevalent may be a strategy for predicting RD in BC, and some genotypes (GSTA1 rs3957356-CT; MAT1A rs2282367-GG) are associated with severe RD.

Keywords: Breast Neoplasms; Genetic Markers; Meta-analysis; Radiodermatitis; Radiotherapy; Single Nucleotide Polymorphisms; Systematic review.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / radiotherapy
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Mad2 Proteins / genetics
  • Polymorphism, Single Nucleotide
  • Radiodermatitis*
  • Risk Factors

Substances

  • MAD2L2 protein, human
  • Mad2 Proteins